atomik labz retatrutide glp-3 GLP-3RT 30mg — 99% HPLC, Triple Agonist GLP-3 (rta) | ELITEPEPPERS

Clinical trials show patients on semaglutide lose 1522% of body weight over 68 weeksa clinically significant result

Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study

Biochimie 2017;136:27-32

In the STEP UP clinical trial, the 7.2-mg dose demonstrated a mean weight loss of 20.7% at 72 weeks, compared with a reduction of 17.5% with the previously approved semaglutide (Wegovy) injection (2.4 mg) and 2.4% with placebo

Lower Blood Sugar GLP-1 meds help your pancreas release insulin when your blood sugar is high, without causing dangerous drops in people who dont have diabetes